Treatment of Nuclear-Donor Cells or Cloned Zygotes with Chromatin-Modifying Agents Increases Histone Acetylation But Does Not Improve Full-Term Development of Cloned Cattle
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
21/10/2013
21/10/2013
2012
|
Resumo |
Although somatic cell nuclear transfer (SCNT) is a promising tool, its potential use is hampered by the high mortality rates during the development to term of cloned offspring. Abnormal epigenetic reprogramming of donor nuclei after SCNT is thought to be the main cause of this low efficiency. We hypothesized that chromatin-modifying agents (CMAs) targeting chromatin acetylation and DNA methylation could alter the chromatin configuration and turn them more amenable to reprogramming. Thus, bovine fibroblasts were treated with 5-aza-2'-deoxycytidine (AZA) plus trichostatin (TSA) or hydralazine (HH) plus valproic acid (VPA) whereas, in another trial, cloned bovine zygotes were treated with TSA. The treatment of fibroblasts with either AZA + TSA or HH + VPA increased histone acetylation, but did not affect the level of DNA methylation. However, treatment with HH + VPA decreased cellular viability and proliferation. The use of these cells as nuclear donors showed no positive effect on pre- and postimplantation development. Regarding the treatment of cloned zygotes with TSA, treated one-cell embryos showed an increase in the acetylation patterns, but not in the level of DNA methylation. Moreover, this treatment revealed no positive effect on pre- and postimplantation development. This work provides evidence the treatment of either nuclear donor cells or cloned zygotes with CMAs has no positive effect on pre- and postimplantation development of cloned cattle. Foundation for the Support of Research of the State of Sao Paulo [FAPESP-2009/06689-5] Foundation for Research Support of the State of Sao Paulo |
Identificador |
CELLULAR REPROGRAMMING, NEW ROCHELLE, v. 14, n. 3, supl. 4, Part 1-2, pp. 235-247, JUN, 2012 2152-4971 http://www.producao.usp.br/handle/BDPI/35246 10.1089/cell.2011.0079 |
Idioma(s) |
eng |
Publicador |
MARY ANN LIEBERT INC NEW ROCHELLE |
Relação |
CELLULAR REPROGRAMMING |
Direitos |
closedAccess Copyright MARY ANN LIEBERT INC |
Palavras-Chave | #IN-VITRO DEVELOPMENT #BOVINE EMBRYOS #DNA METHYLATION #GENE-EXPRESSION #TRICHOSTATIN-A #PREIMPLANTATION DEVELOPMENT #DEACETYLASE INHIBITOR #CLONING EFFICIENCY #PORCINE EMBRYOS #MINIATURE PIG #CELL & TISSUE ENGINEERING #BIOTECHNOLOGY & APPLIED MICROBIOLOGY #GENETICS & HEREDITY |
Tipo |
article original article publishedVersion |